Use of Negative Pressure Wound Therapy in Infected Wounds

Critical Prerequisite: Complete Debridement First

• The World Journal of Emergency Surgery recommends that NPWT should never be applied to infected wounds until complete surgical removal of necrosis has been accomplished, as stated in the 2018 WSES/SIS-E consensus guidelines 1, 2, 3, 4, 5, 6
• Initial surgical debridement should be performed to remove all infected and necrotic tissue, continuing into healthy-looking tissue, before applying NPWT 1, 2, 3, 4, 5, 6

Physiologic Benefits in Infected Wounds

• NPWT increases local blood flow and tissue perfusion, which enhances antibiotic delivery to the wound bed, after adequate debridement 1, 2, 3, 4, 5, 6
• NPWT removes wound exudates and inflammatory fluids, reducing bacterial load and edema, in infected wounds 1, 2, 3, 4, 5, 6
• NPWT promotes granulation tissue formation by removing bacterial contamination and creating a stable wound environment, in infected wounds 1, 2, 3, 4, 5, 6
• NPWT inhibits infection spread by managing wound drainage and preventing fluid accumulation, in infected wounds 1, 2, 3, 4, 5, 6

Evidence Supporting Use in Infected Wounds

• The 2018 WSES/SIS-E guidelines provide a conditional recommendation (1C) to consider NPWT for wound care in necrotizing infections after complete debridement, with a strength of evidence that is not strong enough to prove superiority over conventional dressings 1, 2, 3, 4, 5, 6
• The IWGDF guidelines provide a strong recommendation against using NPWT for non-surgically related diabetic foot ulcers due to lack of evidence 7, 8

Important Caveats and Contraindications

• NPWT should not be applied to wounds with residual necrotic tissue or uncontrolled infection, before adequate debridement 1, 2, 3, 4, 5, 6
• NPWT should not be used for non-surgical diabetic foot ulcers, according to the 2024 IWGDF guidelines 7, 8

Practical Considerations

• Lower pressures (75-80 mmHg) may be appropriate for vulnerable anatomic areas, according to Praxis Medical Insights 9
• Dressing changes should be performed every 2-3 days, with an average of 5 dressing changes required for optimal granulation, according to Praxis Medical Insights 9

Using Wound VAC on Wounds with Exposed Tendon

Critical Prerequisites Before Application

• Complete debridement is absolutely mandatory before applying NPWT to any wound with exposed tendon, to prevent complications including potential fistula formation and treatment failure, according to the International Journal of Surgery 10

Mandatory Technical Requirements

• A large, fenestrated non-adherent interface layer must be placed directly over the exposed tendon to prevent tendon damage during dressing changes, as recommended by the International Journal of Surgery 10, 11
• The interface layer prevents adhesions between the tendon and surrounding tissues, and should be placed as widely as possible, extending beyond the immediate wound margins, as suggested by the International Journal of Surgery 10, 11
• Continuous pressure of 75-80 mmHg should be used rather than the standard 125 mmHg for wounds with exposed tendon, to prevent desiccation of the tendon surface, according to the International Journal of Surgery 12
• Specialized commercial foam-based NPWT dressing kits should be used rather than improvised methods, as they provide constant medial traction and prevent lateral retraction that could compromise healing, as recommended by the International Journal of Surgery 10, 11

Absolute Contraindications

• NPWT should not be used if purulence is present in the wound, and debridement should be performed first, as stated in Circulation 13

Common Pitfalls to Avoid

• Foam should never be applied directly to exposed tendon without the protective interface layer, to prevent tendon damage, as warned by the International Journal of Surgery 10, 11

Contraindications and Non-Candidates for Negative Pressure Wound Therapy

Strong Recommendations Against Use

• The International Working Group on the Diabetic Foot (IWGDF) provides a strong recommendation against using Negative Pressure Wound Therapy (NPWT) for chronic non-surgical diabetic foot ulcers, as all available evidence shows no clear benefit over standard care, with studies suffering from high risk of bias and unclear statistical validity 14, 15
• Four Randomized Controlled Trials (RCTs), two cohort studies, and one case-control study all demonstrated high risk of bias with major methodological flaws, leading to a strong recommendation against NPWT for non-surgical diabetic foot ulcers 14, 15

Common Clinical Pitfalls to Avoid

• Using NPWT in infected wounds before complete necrosis removal prevents the therapy from working effectively, as emphasized by the Diabetes/Metabolism Research and Reviews 15
• Potential adverse effects of NPWT include wound maceration, dressing retention, and paradoxically, wound infection, making patients at high risk for these complications poor candidates 14, 15

Management of Malodorous Wounds Under Negative‑Pressure Wound Therapy

Immediate Actions When Malodor Detected

• Discontinue NPWT immediately, perform radical surgical debridement to healthy‑appearing tissue, obtain deep tissue cultures, and only then consider re‑applying NPWT; foul odor signals residual necrosis or active infection, both absolute contraindications to continued vacuum therapy. 16

Diagnostic Assessment

• During wound inspection look for gray/black necrotic tissue, purulent exudate, undermined edges, exposed structures, and any signs of spreading infection to identify the cause of malodor. 16
• Obtain wound cultures from debrided tissue (not swab) to guide targeted antibiotic therapy. [16][17]

Surgical Debridement

• Radical debridement into bleeding, viable tissue is the single most important step for infection control and subsequent wound healing. [16][17]
• Continue debridement until no necrotic tissue remains and viable bleeding tissue is visible. 16
• Plan for serial debridements every 24–48 h when a single procedure is insufficient. 16

Infection Control and Contamination Prevention

• For perineal or rectal wounds, use a fecal diversion device (e.g., rectal tube) rather than a colostomy; this can be combined with NPWT once infection is controlled. [16][17]
• Protect the wound from ongoing contamination (urine, stool, saliva) according to its anatomical location. 16

Post‑Debridement Wound Dressing Choices

• If NPWT is unavailable, apply standard moist dressings with antimicrobial agents (e.g., polyhexanide spray) and change them daily or twice daily to manage exudate and odor. 18

Monitoring and Indicators of Failure

• At each dressing change, measure the volume of evacuated fluid; a rising amount of purulent drainage signals treatment failure. 17

Contraindications and Situations to Avoid NPWT

• Never re‑apply NPWT to a malodorous wound without prior debridement, as this can seal infection and precipitate sepsis or fistula formation. 16
• The International Working Group on the Diabetic Foot (IWGDF) issues a strong recommendation against using NPWT for chronic non‑surgical diabetic foot ulcers because it provides no benefit over standard care. 18
• Absolute contraindications to restarting NPWT after debridement include:

Guideline Society Recommendations

• The 2018 World Society of Emergency Surgery / Surgical Infection Society‑Europe (WSES/SIS‑E) consensus gives a conditional 1C recommendation for NPWT only after complete necrosis removal; the overall evidence supporting NPWT even under ideal conditions is weak. [16][17]

All facts are presented in English, with patient‑specific details replaced by generic descriptors.